The Year Ahead In Europe: More Price Cuts, More Austerity
Executive Summary
Further austerity plans will be drawn up and drug price cuts implemented in Europe during 2012, as governments try to come to grips with their debts and with the eurozone currency crisis.
You may also be interested in...
Italian Rx Price Cuts Are Brand Pharma’s Pain; Will They Even Be Generics’ Gain?
As Italy’s government turns the austerity screw, physicians will need to be convinced to adopt INN-based prescribing in order for sales to see a boost.
European Regulatory Round-Up: EMA And The UK Heed The Calls Of Industry; France Is Otherwise Occupied
The European Medicines Agency follows through on its transparency initiative with comprehensive list of products under review and also reduces pharmacovigilence data reporting requirements.
European Regulatory Round Up: While EMA Opens Up, European Pharma Battens Down For Tough Year
The European Medicines Agency is focusing on transparency and pharmacovigilance over the next year, while the pharmaceutical industry is gearing up for a fight against austerity measures.